Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Assets (2016 - 2025)

CV Sciences (CVSI) has disclosed Assets for 14 consecutive years, with $7.0 million as the latest value for Q4 2025.

  • Quarterly Assets fell 12.17% to $7.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.0 million through Dec 2025, down 12.17% year-over-year, with the annual reading at $7.0 million for FY2025, 12.17% down from the prior year.
  • Assets hit $7.0 million in Q4 2025 for CV Sciences, roughly flat from $7.0 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $30.7 million in Q1 2021 to a low of $7.0 million in Q4 2025.
  • Historically, Assets has averaged $13.3 million across 5 years, with a median of $9.8 million in 2023.
  • Biggest five-year swings in Assets: tumbled 43.34% in 2022 and later dropped 8.33% in 2025.
  • Year by year, Assets stood at $18.1 million in 2021, then fell by 29.5% to $12.7 million in 2022, then decreased by 27.76% to $9.2 million in 2023, then decreased by 13.84% to $7.9 million in 2024, then fell by 12.17% to $7.0 million in 2025.
  • Business Quant data shows Assets for CVSI at $7.0 million in Q4 2025, $7.0 million in Q3 2025, and $8.0 million in Q2 2025.